Dear Valued Users,
We’re pleased to announce that the T2TKN ($T2TKN) has been listed on Coinstore. To show our gratitude toward users, Coinstore and T2TKN ($T2TKN) will jointly introduce Fixed Savings! Enjoy industry-leading returns of 500% APR!
👉 Subscribe Link:
➡️Subscribe up to 500% APR with T2TKN ($T2TKN) Fixed Savings!
Subscribe Period:
- 7 days: 2024.06.21 18:30:00 - 2024.06.24 18:29:59 (UTC+8)
Savings Detail:
Token | Duration | APR | Min. Purchase | Max. Purchase | Pool Amount |
T2TKN | 7 days | 500% | 500 | 100,000 | 2,950,000 |
- Reward Calculation Period: From Day of Interest, until the expiration date.
- Reward Payout Time: At the estimated time of arrival.
Terms & Conditions:
- Subscribers will receive Earn rewards in T2TKN tokens. The rewards will be sent to Subscribers’ spot accounts.
- The value of digital assets/ digital currencies fluctuates and is subjected to change.
- Fixed Savings does not support early redemption.
- Coinstore reserves the right to disqualify any participants that, in its reasonable opinion, are acting fraudulently or not in accordance with any applicable terms and conditions.
- Coinstore reserves the right to cancel or amend the Promotion or Promotion Rules at its sole discretion.
- Coinstore reserves the right to the final interpretation.
- Where any discrepancy arises between the translated versions and the original English version, the English version shall prevail.
Disclaimer
While cryptocurrencies have significant growth potential, they also come with high market risks and volatility. Users are strongly advised to conduct their own research and invest at their own risk.
Coinstore Global,
21st Jun, 2024
Find us on:
[Official website] https://www.coinstore.com/
[Download Coinstore] https://h5.coinstore.com/download/
[Twitter] https://twitter.com/CoinstoreExc
[Telegram Global Community] https://t.me/coinstore_english
[Telegram Announcement Channel] https://t.me/coinstore_global
[Facebook] https://www.facebook.com/CoinstoreExc/
[Medium] https://medium.com/@coinstore_en
Comments
0 comments
Article is closed for comments.